Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 10,425 |
|
|||||
| News | - | ||||||
| Day High | 1.06 | Low High |
|||||
| Day Low | 0.90 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Arch Therapeutics Inc (QB) | ARTH | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.085 | -8.42% | 0.925 | 16:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.01 | 0.90 | 1.06 | 0.925 | 1.01 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 15 | 10,425 | $ 0.977954 | $ 10,195 | - | 0.39 - 18.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:58:34 | 65 | $ 0.925 | USD |
Arch Therapeutics Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.36M | 1.29M | 1.02M | 76k | -6.98M | -1.47 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Arch Therapeutics (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARTH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.18 | 1.18 | 0.90 | 1.07 | 2,433 | -0.255 | -21.61% |
| 1 Month | 1.73 | 2.07 | 0.90 | 1.22 | 3,330 | -0.805 | -46.53% |
| 3 Months | 2.96 | 3.4275 | 0.90 | 1.90 | 3,797 | -2.04 | -68.75% |
| 6 Months | 0.80 | 18.00 | 0.60 | 5.41 | 16,720 | 0.125 | 15.63% |
| 1 Year | 2.76 | 18.00 | 0.39 | 5.04 | 9,857 | -1.84 | -66.49% |
| 3 Years | 26.00 | 28.00 | 0.39 | 13.80 | 207,260 | -25.08 | -96.44% |
| 5 Years | 75.00 | 75.80 | 0.39 | 27.97 | 265,212 | -74.08 | -98.77% |
Arch Therapeutics (QB) Description
| Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch's products authorized for commercial marketing are AC5 Advanced Wound System and AC5 Topical Hemostat. Arch's development stage product candidates include AC5-GTM and AC5 Surgical Hemostat, among others. |
